Hemab Therapeutics
Series BCopenhagen, DenmarkFeb 2023
Hemab Therapeutics raised €127M in a Series B round in Feb 2023. The company is based in Copenhagen, Denmark. Investors in the round: Access Biotechnology, Avoro Capital Advisors, Deep Track Capital and 6 others. Data as of Nov 2026.
Amount raised
€127M
€126,594,149
Native amount
135,000,000 USD
Stage
Series B
series b
Investors
9
Provenance & confidence
High confidenceAmount
135,000,000 USD
ECB-at-date → €127M · rate 1.0664 on 2023-02-21
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
9 namedAccess BiotechnologyAvoro Capital AdvisorsDeep Track CapitalHealthCapInvusMaj Invest EquityNovo HoldingsRA Capital ManagementRock Springs Capital
Date
Feb 2023
Round type
series b
Amount (EUR)
€127M
Other rounds
same companyThis is the company's only recorded round.
Related news
- Hemab Therapeutics Raises $135M in Series B Financingfinsmes.com · 2023-02